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A B S T R A C T
Background
Prevention of type 2 diabetes in adults is a far better option than treatment, to alleviate pressure on health care providers and resources.
However, there is no current review of the evidence regarding the efficacy of a diet-only intervention for prevention.
Objectives
To assess the effects of type and frequency of dietary advice for the prevention of type 2 diabetes mellitus.
Search strategy
We carried out a comprehensive search of The Cochrane Library, MEDLINE, EMBASE, CINAHL, AMED, bibliographies and
contacted relevant experts.
Selection criteria
All randomised controlled trials, of twelve months or longer, in which dietary advice for the prevention of type 2 diabetes was the only
intervention in adults.
Data collection and analysis
The lead investigator performed all data extraction and quality scoring with duplication being carried out by one of the other four
investigators independently with discrepancies resolved by discussion and consensus. Authors were contacted for missing data. Change
data are presented.
Main results
Two trials which randomised 358 people to dietary treatment and control groups were identified. Longest duration of follow-up was
six years.
In the 6-year Da Qing IGT&Diabetes study, the incidence of type 2 diabetes in the control group was 67.7% (95% confidence interval
(CI) 59.8% to 75.2%) which was reduced to 43.8% (95% CI 35.5% to 54.7%) in the diet group. Overall, the dietary intervention
group had a 33% reduction in the incidence of diabetes after six years (P < 0.03). The Oslo Diet & Exercise Study (ODES) found
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significant (P<0.05) reductions in insulin resistance, fasting insulin (pmol/L), fasting C-peptide (pmol/L), fasting proinsulin (pmol/L),
fasting blood glucose (mmol/L), BMI (kg/m²), mBP (mmHg) and fasting triglycerides (mmol/L), and a significant increase in fasting
HDL cholesterol (mmol/L) and PAI-1 (U/ml) after 12 months of dietary intervention.
Data on mortality, morbidity, health-related quality of life, adverse effects, costs were not reported in either study.
Authors’ conclusions
There are no high quality data on the efficacy of dietary intervention for the prevention of type 2 diabetes. More well-designed, long-
term studies, providing well-reported, high-quality data are required before proper conclusions can be made into the best dietary advice
for the prevention of diabetes mellitus in adults.
P L A I N L A N G U A G E S U M M A R Y
Dietary advice for the prevention of type 2 diabetes mellitus in adults
Two trials randomised 358 participants to dietary advice and control treatment groups. The longest duration of dietary advice was six
years, the only other trial lasted 12 months. Dietary advice appears to be effective in reducing the risk of diabetes by 33% compared
to control group over six years. After 12 months, dietary advice appears to beneficially effect indicators of metabolic control. Data on
mortality, morbidity, health-related quality of life, adverse effects and costs were not reported.
B A C K G R O U N D
Description of the condition
Diabetes mellitus is a metabolic disorder resulting from a defect
in insulin secretion, insulin action, or both. A consequence of
this is chronic hyperglycaemia (elevated levels of plasma glucose)
with disturbances of carbohydrate, fat and protein metabolism.
Long-term complications of diabetes mellitus include retinopa-
thy, nephropathy and neuropathy. The risk of cardiovascular dis-
ease is increased. For a detailed overview of diabetes mellitus,
please see under ’Additional information’ in the information on
the Metabolic and Endocrine Disorders Group on the Cochrane
Library (see ’About the Cochrane Collaboration’, ’Collaborative
Review Groups-CRGs’). For an explanation of methodological
terms, see the main Glossary in The Cochrane Library.
Type 2 diabetes mellitus is a very common chronic disease. The
prevalence of the disease is increasing across the world and is linked
with the adoption of a ’Western’ lifestyle, mainly in terms of di-
etary habits and physical activity (Torjesen 1997). Around 80%
of individuals who develop type 2 diabetes are initially obese (
Hensrud 2001), which is known to further contribute to an in-
creased insulin resistance (Pi-Sunyer 2000). There is a strong fa-
milial predisposition to developing the disease; first-degree rela-
tives of known type 2 diabetic patients are at an increased risk of
developing the disorder (Martin 1992), indicating that in some
cases, people are genetically predisposed to this disease. However,
little is known about the genetics of diabetes and some studies have
shown that environmental and lifestyle factors are muchmore im-
portant determinants. Therefore, a wide-scale genetic screening
strategy would be ineffective and wasteful to resources. Ageing and
increased sedentary behaviour are also associated with the appear-
ance of the disease. A new cause for concern is that recently type
2 diabetes has started to affect the obese paediatric population (
Sinha 2002).
There are an estimated 2.35 million people with diabetes in Eng-
land, with up to another 750,000 undiagnosed cases and this
is predicted to grow to more than 2.5 million by 2010 (DOH
Website; Diabetes UK Website). Type 2 diabetes mellitus is the
more common of the two main types and accounts for between
85% to 95% of all diabetic patients (Diabetes UKWebsite). In the
United Kingdom alone, treatment of type 2 diabetes costs around
£1.8 billion per annum (Moore 2000), which is predicted to grow
if this epidemic is left alone without implementation of a strong,
effective and strategic prevention program. In the World Health
Organisation report (WHO/FAO 2003), it was suggested that the
changes needed to reduce the risk of developing type 2 diabetes
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at a population level would be unattainable unless substantial en-
vironmental changes to facilitate individual choices were imple-
mented.
Risk factors for type 2 diabetes include population group, age,
obesity, waist-to-hip ratio, low birth weight, family history of dia-
betes, history of gestational diabetes and physical inactivity. How-
ever, the precise detail of how these risk factors affect the patho-
physiology of disease is not well understood (Goldberg 1998).
It is estimated that newly diagnosed diabetic patients have been
hyperglycaemic for 5 to10 years before diagnosis, with 10% to
20% already having some tissue complications (Goldberg 1998).
Improved understanding of the development of type 2 diabetes
suggests that this disease has a prolonged prediabetic phase, giving
hope that individuals who are at high risk of becoming diabetic
might be identified before the disease progresses and given pre-
ventative treatments.
Insulin resistance is usually the first clinically detectable stage in
the evolution of type 2 diabetes (Goldberg 1998) and in theory,
screening on this basis would appear particularly interesting as
this may lead to practices that could reduce insulin resistance and
therefore retard or prevent the development of type 2 diabetes
and its associated complications. However, it is estimated that al-
though 25% of the population would be defined as insulin resis-
tant, only 5% to 6% of the population would develop diabetes (
Goldberg 1998). All individuals who develop type 2 diabetes pass
through the impaired glucose tolerance (IGT) phase, caused by
malfunctioning ß-cells, and defined by theWorld Health Organi-
sation (WHO) as a fasting glucose <140mg/dL and a 2-hour glu-
cose value of 140 to 199mg/dL after 75g of oral glucose. Factors
which increase the risk of progression from IGT to type 2 diabetes
include high fasting and 2-hour glucose measurements, glycated
haemoglobin, ethnicity and obesity, but themost important deter-
minant is the severity of the glucose intolerance (Goldberg 1998).
Description of the intervention
A person with newly diagnosed diabetes is usually offered time
with a dietitian who will show them how to reduce their fat intake
and increase their complex carbohydrate intake, although dietary
advice can be offered by any trained health care professional. How-
ever, by this stage the disease has already been diagnosed and it is
too late for any prevention strategies. The dietitian can only treat
the disease and help to prevent, or slow down, the progression of
diabetes towards more serious complications. An effective preven-
tion mechanism is required to suppress this epidemic as 25% to
75% of those with IGT, develop diabetes within a decade of their
diagnosis (Saad 1988)
Diets commonly used to control blood glucose levels include low
fat and high unrefined carbohydrate, (those which take around
25% to 30%of energy from fat and around 50%of the total energy
from unrefined carbohydrate), or low glycaemic index (GI) diets
(foods that have a low glycaemic index include pasta products,
oats, beans and some fruits and vegetables) usually both in com-
bination with weight reducing advice. Diets based on glycaemic
index of food have lately come into vogue, and Brynes published a
letter reporting a short trial which showed that a low glycaemic in-
dex diet significantly improved the 24-hour blood glucose profile
in type 2 diabetics (Brynes 2003). Two systematic reviews in this
area for the Cochrane Collaboration published conflicting recom-
mendations, regarding the usefulness of low GI diets (Kelly 2004;
Thomas 2007).More recent research has also looked into the effect
of individualmacro- andmicro-nutrients such as fibre, chromium,
and so called ’functional foods’, but much of this evidence seems
to be incomplete, with relatively few intervention trials carried
out long-term (Riccardi 2005). However, it is thought that similar
diets may be of value in those with metabolic syndrome in pre-
venting or delaying progression to frank diabetes (Riccardi 2000).
The use of a high polyunsaturated or high monounsaturated fat
diet has been investigated with regards to weight and diabetes. In
1998, Garg reviewed the use of high monounsaturated fat diets
compared with traditional high-carbohydrate diets and found that
the monounsaturated fat diet actually both increased HDL and
reduced fasting triglycerides and VLDL-cholesterol (Garg 1998).
Brynes et al. published a report of a short trial, which did not show
any association between an increase in dietary fat and a change in
insulin sensitivity (Brynes 2000).
Why it is important to do this review
There is now unequivocal evidence that type 2 diabetes can be
prevented or at least delayed by interventions including a dietary
component. Risk of such progression was decreased by over half
in the two major trials to date (DPP 2002b; Tuomilehto 2001).
The United States Diabetes Prevention Program, (which was in-
eligible for inclusion in this review), reported a reduction of 58%
(95% confidence interval (CI) 48% to 66%) in the incidence of
diabetes when participants were treated with the lifestyle inter-
vention compared with a 31% reduction (95% CI 17% to 43%)
of incidence of diabetes for the metformin-treated participants (
DPP 2002b), which demonstrates that progression from impaired
glucose tolerance to type 2 diabetes mellitus is not inevitable with
appropriate lifestyle intervention.
However, we are not aware of the existence of any systematic re-
views addressing the impact of dietary advice alone on the pre-
vention of type 2 diabetes. A review by Anderson and colleagues
(Anderson 2003), carried out on the subject of ’Importance of
Weight Management in Type 2 Diabetes’, suggested that “the
United States health care providers should endorse the American
Heart Association’s and European Diabetes Association’s recom-
mendations that diabetic people .. achieve and maintain a BMI
equal to or less than 25 kg/m2” and that “weight management
may be the most important therapeutic task for most obese type
2 diabetic individuals”.
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Despite the large body of evidence supporting dietary treatments,
the authors of this review also recognise the importance of lifestyle
changes and the impact of physical activity. In general, support
is given for a multifaceted approach to diabetes prevention. It is
therefore advised that in practice, this review is read alongside other
Cochrane diabetes prevention reviews such as ’Long-term non-
pharmacological weight loss interventions for adults with predi-
abetes’ (Norris 2007) and the upcoming review by Orozco et al
which is in protocol format at the moment ’Exercise or exercise
and diet for preventing type 2 diabetes mellitus’ (Orozco 2007)
which covers topics outside the scope of this review. However,
given the prevalence of type 2 diabetes and the potentially serious
costs (health status and financially) of the disease, it is important
to establish which type of dietary advice, if any, is most effective
in preventing development.
This Cochrane review therefore aims to assess the evidence that
exists to establish what kind of dietary advice is effective in pre-
venting development of type 2 diabetes mellitus in adults.
O B J E C T I V E S
To assess the effects of type and frequency of dietary advice for the
prevention of type 2 diabetes mellitus.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled clinical trials (RCTs) that followed pa-
tients for at least twelve months were included. Randomisation of
individuals or clusters of individuals were accepted.
Types of participants
All studies had to include adult participants who were 18 years or
older.
To be consistent with changes that have occurred over time in
the classification and diagnostic criteria of impaired glucose toler-
ance, the diagnosis should have been established using the stan-
dard criteria valid at the time of the beginning of the trial. Ideally,
the diagnostic criterion was described in the article. Diagnostic
criteria used included those described by the National Diabetes
Data Group standards (NDDG 1979), the World Health Organ-
isation standards (WHO 1980; WHO 1985; WHO 1998) and
the American Diabetes Association Standards (ADA 1997; ADA
1999; ADA 2002).
Studies performed on participants suffering from impaired glucose
tolerance were included in this review. Where a study reported
combined results for participants with type 2 diabetes and partic-
ipants with impaired glucose tolerance, then efforts were made to
contact the authors of the study to obtain individual patient data.
Where this was unsuccessful, the trial was excluded.
Participants could be of either sex, but those who were acutely ill
or pregnant were excluded.
Types of interventions
Studies where the intervention was dietary advice with an aim of
reducing weight and risk of developing type 2 diabetes mellitus
were included in this review. Studies that compared the effects of
dietary advice versus no dietary advice or dietary advice versus dif-
ferent dietary advice were also included. Studies were not included
if they included medication that was provided differently in the
control and intervention groups.
Types of outcome measures
Primary outcomes
• Incidence of type 2 diabetes.Ideally, the diagnostic criteria
for type 2 diabetes mellitus should have been described in the
trial. To be consistent with changes in classification and
diagnostic criteria of the disease through the years, the diagnosis
should have been established using the standard criteria valid at
the time of the beginning of the trial. Changes in the diagnostic
criteria may have produced significant variability in the clinical
characteristics of the patients included as well as in the results
obtained. These differences were considered and planned to be
explored in a sensitivity analysis;
• Glycaemic control measures (oral glucose tolerance test,
both fasting and 2-hour and glycated haemoglobin; for the
detection of impaired glucose tolerance);
• Time to development or diagnosis of type 2 diabetes
mellitus.
Secondary outcomes





• body mass index (BMI);
• Cost of intervention(s);
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• Serum cholesterol (LDL and/or HDL) and serum
triglycerides;
• Blood pressure;
• Maximal exercise capacity;
• Adverse effects.
Timing of outcome measurement
Randomised controlled trials of interventions that involved par-
ticipants for a minimum of twelve months were included in the
review. Outcomemeasures were extracted and assessed at baseline,
one year, two year and at one year intervals from that point where
available.
Search methods for identification of studies
Electronic searches
We used the following sources for the identification of trials: The
Cochrane Library, which includes the Cochrane Central Regis-
ter of Controlled Trials, the Database of Systematic Reviews and
the Database of Abstracts and Reviews of Effectiveness (issue 4,
2007), MEDLINE (until November week 2, 2007), EMBASE
(until week 50, 2007), CINAHL (until December week 1, 2007)
and AMED (until December 2007). There were no language re-
strictions for either searching or trial inclusion.
The described search strategy (see for a detailed search strategy
Appendix 1) was used for MEDLINE. For use with EMBASE,
The Cochrane Library and the other databases this strategy was
slightly adapted.
We also searched databases of ongoing trials: Current Con-
trolled Trials (http://www.controlled-trials.com - with links to




References of the 132 full text journal articles were screened for
potentially relevant articles.
Data collection and analysis
Two reviewers undertook assessment of results data independently.
Results data were assessed by the lead reviewer (LN) and dupli-
cated by one of the co-reviewers (either HM, VW, CS or LH).
Information on a number of measures of methodological qual-
ity of the included studies was assessed independently by two re-
viewers (LN plus one other from HM, VW, CS or LH); study
design, method of allocation concealment, blinding of outcome
assessment and drop out rates. Where there was uncertainty, au-
thors were contacted to clarify aspects of study design. Differences
between reviewers’ extraction results were resolved by discussion.
Multiple publications were collated and assessed as one study.
Selection of studies
In the first instance, relevant studies were determined from the
initial search of electronic databases, and then through screening
by the lead reviewer (LN) andduplicated by one of the co-reviewers
(either HM, VW, CS or LH). Articles were rejected during this
initial screening if the reviewer could determine from the title or
abstract that it did not meet the inclusion criteria, if rejection was
not possible, full text copies were retrieved.
Data extraction and management
Two reviewers (the lead reviewer (LN) plus one other from either
HM, VW, CS or LH) independently extracted data from each
study using a data extraction form based on the one provided by
the Metabolic and Endocrine Disorders Review Group. Differ-
ences between reviewers’ extraction results were resolved by discus-
sion, and where necessary, in consultation with a third reviewer.
Data concerning participants, interventions, and outcomes, as de-
scribed in the selection criteria section, were extracted. Trial qual-
ity characteristics, including method of randomisation, allocation
concealment, blinding of outcome assessors and losses to follow-
up, were extracted onto the form. In addition, data were collected
on potential effect modifiers including age, presence of diabetic
micro or macrovascular disease, blood pressure, lipids, body mass
index and bodyweight.
Assessment of risk of bias in included studies
The quality of each trial was assessed based largely on the quality
criteria specified by Jadad andSchulz (Jadad 1996; Schulz1995) by
the lead reviewer (LN) and duplicated by one of the co-reviewers
(either CS, HM, VW or LH). Interrater agreement was reviewed.
In particular the following factors were looked at:
(1) Minimisation of selection bias - score: 0 or 1 or 2.
(a) one point was given if the study could be described as ran-
domised (which includes the use of words such as ’random’, ’ran-
domly’ and ’randomisation’);
(b) one additional point was given if the study described the
method of randomisation and was an appropriate method;
(c) one point was taken away if the study described the method of
randomisation, but was an inappropriate method.
(2) Minimisation of detection bias - score: 0 or 1 or 2.
(a) one point was given if the study was described as blinded (in
any capacity);
(b) one additional point was given if the method of blinding was
described and was appropriate;
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(c) one point was taken away if themethod was described as blind-
ing but was inappropriate.
(3) Minimisation of attrition bias - score: 0 or 1.
(a) one point was given if the withdrawals and dropouts from the
study are described.
We did not score on performance bias.
Based on these criteria, studies were broadly subdivided into the
following three categories (see CochraneHandbook for Systematic
Reviews of Interventions):
A - all quality criteria met: low risk of bias (studies with scores of
four and five points (and with at least one point allocated from
each section) were allocated to this category).
B - one or more of the quality criteria only partly met: moderate
risk of bias (studies with scores of three points (and with at least
one point in each section) were allocated to this category).
C - one or more criteria not met: high risk of bias (S´ studies with
scores of zero, one, two and three points were allocated to this
category (that is studies with no points in at least one section)).
These subdivisions of the studies were used as the basis of a sen-
sitivity analysis, if the included studies receive notably different
quality scores. Quality scores and categories were reported in the
’characteristics of included studies’ table.
Measures of treatment effect
Endpoint versus change data:Where possible, change data are pre-
sented. Change data were calculated from endpoint data - baseline
data if only endpoint data were presented.
Data for the Da Qing study (Pan 1997) were presented with base-
line and endpoint data (after six years), therefore the mean change
data were calculated manually by the lead reviewer (checked by a
co-reviewer) using endpoint - baseline = change (LN, HM), with
baseline standard deviations assumed equal to endpoint.
There were no continuous outcomes, however, in the case of such
data, a weighted mean difference (WMD) between groups would
have been estimated.
Assessment of heterogeneity
A test for heterogeneity was planned, using the standard χ2-test, as
well as by visually inspecting the graphs (the I2-test was planned to
be used to quantify heterogeneity (Higgins 2002). If there was lit-
tle heterogeneity between trial results, data would be summarised
statistically using a fixed effect model for continuous data. A sig-
nificance level less than 0.10 would have been interpreted as evi-
dence of heterogeneity. If heterogeneity was found, the data would
be re-analysed using a random effects model to see if this made a
substantial difference. However, because of the lack of data, there
were no meta-analyses carried out, so testing for heterogeneity
could not be carried out.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were planned a priori but were not undertaken
as they were not applicable to the included studies. These sub-
group analyses were planned to assess whether particular groups of
people with type 2 diabetes could obtain more benefit from a par-
ticular intervention than other groups could. Efficacy of different
combinations of types of diets would have also been considered in
the subgroup analyses.
The main analysis carried out were as follows:
• Dietary advice versus a different dietary advice
Subgroup analyses for this comparison would have been:
• dietary advice in lean participants versus the same dietary
advice in obese participants;
• with or without weight loss advice (outcome measures:
development of (further) microvascular disease only);
• presence/absence of microvascular disease (outcome
measures: development of (further) microvascular disease only).
However, due to there only being two papers included, there was
insufficient data to carry out any subgroup analyses.
Sensitivity analysis
No sensitivity analyses were performed.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
The search identified 4078 records, from these, 132 full papers
were identified for further examination and assessed independently
by two reviewers (LN plus one other from HM, CS, LH or VW).
The other studies were excluded on the basis of their abstracts
because they were not relevant to the question under study (see
Figure 1 for details of the amended QUOROM (quality of report-
ing of meta-analyses) statement). After screening the full text of
the selected papers, five papers were found which met the inclu-
sion criteria, referring to two studies; Da Qing IGT and Diabetes
Study (Pan 1997) and the Oslo Diet and Exercise Study (ODES)
(Torjesen 1997).
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Figure 1.
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Assessment of publication bias inter-rater agreement
Inter-rater agreement for study selection, qualifying a study as
’included’ or ’potentially’ relevant, was very high between the lead
reviewer (LN) and all co-reviewers (HM, CS, VW and LH).
Missing data
Attempts were made by the lead reviewer to contact the lead au-
thors in the event of data which has been reported or recorded but
not published in the text of the articles. A reply was received from
Torjesen (Torjesen 1997). However, further information for the
Pan (Pan 1997) study was untraceable. There was a third study
(Swinburn 2001) which had potential to be included, but some
participants were diabetic at the start of the study, attempts were
made to contact the authors, but no further information could be
retrieved.
Included studies
Two studies met the inclusion criteria. The Oslo Diet & Exercise
Study (ODES) looked at an increased intake of fish and reduced
total fat intake (Torjesen 1997), and the Da Qing IGT and Di-
abetes Study looked at prescription of a diet based upon body
weight (25 to 30 kcal/kg), increased consumption of vegetables,
and a reduction of simple sugars and alcohol (Pan 1997).
Interventions
The participants in the trial lead by Pan (Pan 1997) were ran-
domised by clinic to one of four groups: diet only, diet plus exercise,
exercise only and control. For the purpose of this review, only the
diet and control groups were eligible for comparison. Participants
with a body mass index (BMI) less than 25kg/m² were prescribed
a diet containing 25 to 30kcal/kg body weight which consisted of
55% to 65% carbohydrate, 10% to 15% protein and 25% to 30%
fat. These participants were asked to consume more vegetables,
limit their alcohol consumption, and reduce their intake of sim-
ple sugars. Individuals with a BMI greater than 25kg/m² were en-
couraged to reduce their calorie intake in order to promote weight
loss of 0.5 to 1.0 kg per month until they reached a target BMI
of 23 kg/m². Targets were set for individuals for total calorie con-
sumption, and quantity of cereals, vegetables, milk, meat and oils.
This was promoted by the provision of a list of the recommended
daily intake of commonly used foods and a substitution list which
allowed exchanges within a food group. All participants received
individual counselling by physicians concerning their daily food
intake, with small group counselling sessions running weekly dur-
ing the first month, monthly for the first three months, and three-
monthly for the remainder of the study. Participants from clinics
assigned to the control group were provided with general informa-
tion about diabetes and impaired glucose tolerance (IGT). Physi-
cians also handed out some leaflets with general instructions for
diet and/or increased leisure time physical activity. No individual
instruction or group counselling sessions were held.
In the Oslo Diet and Exercise Study (ODES) (Torjesen 1997),
participants were again randomised to four groups: diet only, diet
plus exercise, exercise only and control. The diet intervention was
individualised and provided individually for each participant with
their spouse (Holme 1993). The dietary counselling encouraged
a decrease in the total caloric intake, included increased intake of
fish and fish products and a reduced total and saturated fat intake.
In addition, participants were advised to increase their intake of
vegetables and fibre-rich complex carbohydrate products and a de-
crease their intake of sugar. Participants with high blood pressure
were also requested to decrease their intake of salt. During the
counselling sessions, a target body weight reduction was agreed
on, typically of 0.5 to 1.0kg per month, but as high as 2 kg/month
for the most overweight individuals. At the end of the session,
each participant was given an individualised dietary programme,
including the 5 to 10 most important points. Participants were
asked to record their body weight weekly. Their dietary habits were
followed up at three and nine months into the study. All partici-
pants in the control group, were asked not to change their dietary
habits or lifestyle during the trial, but, as with all participants, they
were asked to stop smoking.
Number of study centres
In the Da Qing IGT and Diabetes Study, there were 33 clinics
involved (Pan 1997) compared with only one in the Oslo Diet
and Exercise Study (Torjesen 1997).
Country and location
Of the two studies which compared dietary advice to a control
group, one was based inDaQing, Hei Long Jiang Province, China
(Pan 1997) and one in Oslo, Norway (Torjesen 1997).
Setting
All of the participants were home-based or free-living but received
dietary advice by attending a clinic (Pan 1997) or at a university
hospital (Torjesen 1997).
Treatment before study
Participants for the Oslo Diet and Exercise Study (Torjesen 1997)
were recruited from an ongoing screening program of 40-year old
men and women in Oslo, participants in the Da Qing IGT and
Diabetes Study (Pan 1997) agreed to take part in the randomised
controlled trial after they were identified during an on-going pop-
ulation-based survey of diabetes and IGT in Da Qing, China.
Methods
Pan (Pan 1997) randomised participants by clinic for the con-
trolled clinical trial to investigate the effects of diet, exercise and
diet plus exercise on the incidence of diabetes in people with im-
paired glucose tolerance (IGT). Participants were also split into
two sub-groups according to their BMI- ’overweight’ was defined
as participants with BMI greater than 25 kg/m² and ’lean’ as par-
ticipants with BMI less than 25 kg/m². After their initial screen-
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ing, participants attended a general health check at three-month
intervals with a local physician and discussed compliance with the
intervention with nurses and clinical staff. At each three month
follow-up visit, weight, blood pressure and urinary glucose were
measured. If the urinary glucose appeared positive, further diag-
nostic tests were carried out. Firstly, plasma glucose was measured
two hours after a standard breakfast of 100g steamed bread. If this
postprandial glucose concentration was >200mg/dl (11.1mmol/
l), or the physician suspected that the participant had developed
diabetes, the subject received a 75g oral glucose tolerance test at
the hospital. If at any time during the study, a participant had
symptoms of diabetes and repeated fasting plasma glucose mea-
surements greater than 140 mg/dl (7.8 mmol/L) or a one-off glu-
cose measurement was greater than 200 mg/dl (11.1 mmol/L),
a clinical diagnosis of diabetes was made. If the participant met
WHO criteria for diabetes following these test, their formal par-
ticipation in the study ended. Every two years, all participants
(including those diagnosed with diabetes at their 3-month check
ups) underwent a systematic evaluation examination where their
height, weight, blood pressure, fasting plasma glucose and 2-hour
plasma glucose were reviewed. If results indicated diabetes (fasting
glucose greater than 140 mg/dl [7.8 mmol/L] or 2-hour glucose
greater than 200mg/dl [11.1 mmol/L]) then the oral glucose tol-
erance test was repeated 7 to 14 days later. If diagnosis of diabetes
was confirmed, the participant was referred to standard diabetes
treatment. If the repeat results were below diabetic levels, then the
participant continued in the study.
The Oslo Diet and Exercise Study (Torjesen 1997) was a 2x2 ran-
domised primary preventative trial, forming four groups- diet, ex-
ercise, diet and exercise and control groups from the two interven-
tions- physical exercise and dietary change. All participants were
selected from a database of men and women who complied with
a number of inclusion criteria. Insulin, C-peptide, proinsulin and
glucose were measured at baseline and at 12 months from serum
drawn before and 60-minutes after a 75g standard oral glucose
load. All measurements were determined from one assay series
for each participant. Analyses were performed in batches at the
end of the trial from frozen samples. Insulin was assayed by a ra-
dioimmunoassay using an antibody which had no cross-reaction
against pro-insulin or des 31,32 split pro-insulin. C-peptide was
assayed by radioimmunoassay with a 5% cross-reaction against
pro-insulin (provided by Diagnostic System Laboratories, Web-
ster, Texas). Pro-insulin was measured by an immunometric assay
using monoclonal antibodies against the insulin and C-peptide
parts. Other components were measured using standard methods.
Insulin resistance and relative ß-cell function were calculated from
the fasting serum levels of glucose and insulin. Insulin resistance
and relative ß-cell for each participant was determined using for-
mulae. Each participant was examined for all risk factors at base-
line and year 1 of the study. This included an assessment of family
history, patient history of earlier disease, a description of exercise,
eating and smoking habits and a full physical examination. Some
measurements such as cholesterol, HDL-cholesterol and triglyc-
erides were also taken at three and nine months for those who were
in the dietary advice group.
Duration of the intervention
Recruitment for the Pan et al. study (Pan 1997) was completed
in 1986 and the intervention was carried out for six years. Partic-
ipants received individual counselling weekly for the first month,
monthly for the first three months, and three-monthly for the rest
of the study. Systematic evaluation assessments were carried out
every two years in 1988, 1990 and 1992.
Participantswere involved in the interventionperiod for a duration
of 12months in theOsloDiet andExercise Study (Torjesen 1997).
Duration of follow-up
Follow-up of the Pan study (Pan 1997) was continued for six years,
at two year intervals in 1988, 1990 and 1992, with data published
for baseline and 6-year endpoint.
In theOsloDiet and Exercise Study, follow-up was only continued
for one year with data collected at baseline and one-year time
points (Torjesen 1997).
Run-in period
There were no run-in periods reported for either of the two studies.
Language of publication
Both of the studies were published in English (Torjesen 1997 and
Pan 1997).
Participants
The two trials followed 358 participants. There were 176 in the
control groups and 182 in the intervention groups. The samples
used in these trials were generally representative of the population,
as the majority were recruited from ongoing mass screening pro-
grammes.
Who participated
Participants in the Oslo Diet and Exercise Study (Torjesen 1997)
were recruited from an on-going screening programme, all partic-
ipants were aged 41 to 50 years old and were male and female.
Male (n = 132) and female (n = 131) participants over the age of
25 were recruited for the Da Qing IGT and Diabetes Study (Pan
1997) for the diet and the control groups. For the control group,
mean age was 46.5 ± 9.3 years and for the diet group was 44.7 ±
9.4 years. Participants were screened to ensure that they fulfilled
the inclusion criteria (described below).
Inclusion criteria
All participants in the Da Qing IGT and Diabetes Study (Pan
1997) lived inDaQing, were over the age of 25 and received health
care at one of the designated health clinics which were chosen
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to participate in the study (roughly half of all Da Qing’s clinics).
Detailed inclusion criteria were not described.
The Oslo Diet and Exercise Study (Torjesen 1997) selected par-
ticipants from the on-going screening programme who were rela-
tively inactive (exercised once a week at themost and characterised
by a maximal oxygen uptake [VO2max] of 35.4 ± 5.9 ml/kg/min)
as measured by a questionnaire, with a BMI greater than 24kg/m²,
diastolic blood pressure of 86 to 99 mmHg, total cholesterol of
5.20 to 7.74mmol/L, HDL-cholesterol of less than 1.20 mmol/L,
and fasting triglycerides greater than 1.4 mmol/L at the initial
screening. All criteria had to be fulfilled, as well as there being
no obvious signs of cardiovascular disease or diabetes present, and
that no drugs were being used that might have interfered with the
accuracy of the test results.
Exclusion criteria
Participants were excluded from the Da Qing IGT and Diabetes
Study if theywere less than25kg/m² (Pan1997). Further exclusion
criteria were not described.
Participants were excluded if they had any symptoms of cardio-
vascular disease, or diabetes at the initial screening, or if unsuit-
able drugs were being used which could impede the test results (
Torjesen 1997).
Diagnostic criteria
Pan (Pan 1997) used the 1985 WHO criteria (WHO 1985) to
diagnose participants with diabetes by 2-hour glucose greater than
11.1mmol/l or with fasting hyperglycaemia by fasting plasma glu-
cose greater than 7.8 mmol/L.
Torjesen (Torjesen 1997) diagnosed participants with insulin re-
sistance by using the following formulas:
• resistance= (insulin/7.2) / (22.5/glucose);
• relative ß-cell function (%) = (20 x insulin/7.2) / (glucose-
3.5);
• insulin was divided by 7.2 to obtain milli-units per litre
from picomoles per litre.
Co-morbidities
During the 6-year follow-up of the Pan (Pan 1997) study, there
were some fatalities reported, however, none were diabetes related.
No co-morbidities were recorded for the Torjesen paper (Torjesen
1997).
Co-medications
Noco-medicationswere recorded for the Torjesen (Torjesen 1997)
or Pan (Pan 1997) studies.
Excluded studies
127 publications had to be excluded after careful evaluation of the
full publication.Main reasons for exclusionwere that the studywas
not a randomised control trial (n=88) or that the intervention was
lifestyle and not diet alone (n=10) (for details see Characteristics
of excluded studies).
Risk of bias in included studies
For details on methodological quality of included studies see
Appendix 2. Generally, the quality of the studies was quite poor.
Risk of bias was assessed by the lead author only.
Allocation
Methods of randomisation were not described for the Da Qing
IGT and Diabetes Study (Pan 1997). The methods of randomi-
sation for the Oslo Diet and Exercise Study were not described,
however, randomisation was stratified by gender (Holme 1993).
Allocation concealment was not described in either paper.
Blinding
Method of blinding was not described in the Da Qing IGT and
Diabetes Study (Pan 1997) paper. The Oslo Diet and Exercise
Study was unmasked, but blinded for the objective blood analyses
(Torjesen 1997).
Incomplete outcome data
All patients were screened initially and selected on the basis that
they fulfilled all inclusion criteria. They were then randomised
either by clinic (Pan 1997) or on an individual basis (Torjesen
1997). However, Pan (Pan 1997) reports that 47 out of the 577
original participants (8%) did not complete the study. Seven peo-
ple refused follow-up, 29 left Da Qing in 1988 and 11 died from
non-diabetic related illnesses. In the control group, there was one
death from pneumonia and two from cirrhosis, and three deaths
in the diet group (two from cancer, and one from septicaemia).
There were no drop-out rates reported for the Torjesen paper (
Torjesen 1997).
Definition of primary endpoint and secondary endpoints
Initially, the reviewers were studying the following primary out-
comes: incidence of type 2 diabetes; glycaemic control measures
(oral glucose tolerance test, both fasting and 2-hour and glyco-
sylated haemoglobin; for the detection of impaired glucose toler-
ance); time to development or diagnosis of type 2 diabetes melli-
tus. The secondary outcomes that wewished to study were: quality
of life (ideally, measured using a validated instrument); mortality;
morbidity; weight; BMI; cost of intervention(s); serum choles-
terol (LDL and/or HDL) and serum triglycerides; blood pressure;
maximal exercise capacity and adverse effects.However, due to the
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limitations of the data available in the papers which were available
for inclusion, many of these endpoints could not be studied.
Power calculation
Power calculations were not performed for these studies.
Intention-to-treat and per-protocol analyses, missing data
Intention-to-treat, per-protocol analyses and procedures for miss-
ing data were not reported in these studies.
Compliance measures
Pan (Pan 1997) did not report any compliance measures, but it
appeared that compliance was measured by attendance to clinics
and by discussion with nurses and clinical staff.
Compliance data for the ODES were reported. At three and nine
months, a blood sample was taken and analysed for HDL-choles-
terol, triglycerides and total cholesterol. Each participant was also
asked to respond to a 180 item food frequency questionnaire. The
results of both were discussed with the participants to encourage
compliance.
Funding
Sources of funding were not discussed in either paper.
Publication status
Both papers were published in Diabetes Care, a peer-reviewed
journal.
Effects of interventions
From the included studies, no meta-analytic comparisons could
be made due to insufficient information. However, data were in-
putted into the table to allow future comparisons to be made of
one type of dietary advice versus another different type of dietary
advice for a small number of outcomes including body mass index
(BMI), weight and fasting glucose at a limited number of time
points.
Baseline characteristics
For details of baseline characteristics see Appendix 3.
For details of adverse events, primary and secondary outcomes see
Appendix 4, Appendix 5 and Appendix 6
Dietary advice versus control
The two studies reported one type of dietary advice versus a control
group which were provided with basic information. The Da Qing
IGT and Diabetes Study (Pan 1997) randomised 163 participants
to the two groups, and presented data at baseline and at the 6-year
endpoint. The incidence of type 2 diabetes in the control group
was 67.7% (95% confidence interval (CI) 59.8 to 75.2%) which
was reduced to 43.8%(95%CI35.5% to54.7%) in the diet group.
Overall, the dietary intervention group had a 33% reduction in the
incidence of diabetes after 6 years (P < 0.03). Defined by WHO
criteria (WHO 1985), the incidence of diabetes was 15.7/100
person-years (95% CI 12.7% to 18.7%) for the control group,
and 10.0/100 (95% CI 7.5% to 12.5%) person-years in the diet
group which was significantly different (P < 0.05). Fasting plasma
glucose increased by 2.07 ± 0.82 mmol/L in the control group
and 1.38 ± 0.81 mmol/L in the diet group. 2-hour plasma glucose
increased by 3.96 ± 0.89 mmol/L in the control group and 1.48
± 0.94 mmol/L in the diet arm. As dietary treatment and advice
differed for participants of BMI less than 25kg/m² (lean) and
participants with a BMI greater than 25kg/m² (overweight), some
analyses were done to compare the two sub-groups. Incidence rates
of diabetes in the control group of overweight participants were
higher than incidence in the lean participants control group (17.2
versus 13.3/100 person years [P < 0.05]). In the lean participants,
the incidence of developing diabetes was not significantly changed
by the dietary intervention.
The Oslo Diet and Exercise Study (Torjesen 1997) presented data
from 95 participants in two groups at baseline and at the 1-year
endpoint. Many variables were measured at 0 and at 12 months
with significant differences (P < 0.05) being found in change data
measurements for the following (reported as diet group and control
group respectively): insulin resistance -0.4 ± 0.2 versus 0.2 ± 0.2;
fasting insulin (pmol/L) -7 ± 4 versus 4 ± 6; fasting C-peptide
(pmol/L) -163 ± 49 versus -92 ± 53; fasting proinsulin (pmol/L)
-2.2 ± 1.1 versus 1.6 ± 1.2; fasting blood glucose (mmol/L) -0.2
± 0.1 versus 0.0 ± 0.1; BMI (kg/m²) -1.3 ± 0.2 versus 0.4 ± 0.1;
mBP (mm Hg) -5.2 ± 1.1 versus -1.5 ± 1.5; fasting triglycerides
(mmol/L) -0.3 ± 0.2 versus -0.1 ± 0.3; fasting HDL-cholesterol
(mmol/L) 0.06 ± 0.04 versus -0.05 ± 0.03 and PAI-1 (U/ml)
0.9 ± 3.8 versus 2.4 ± 3.3 . Weight was also measured (but not
published), and noticeable differences were found between the diet
group and the control group respectively at 12 months; weight
(kg) -6.8 ± 19.5 versus 1.1 ± 13.8 although no significance level
was published by the authors.
Incidence of type 2 diabetes
Pan (Pan 1997) reported incidence of diabetes for all groups of
participants. As defined by WHO criteria (WHO 1985) the per-
centage of participants with 2-hour plasma glucose greater than
11.1mmol/L was 67.7% (95% CI 59.8% to 75.2%) for the con-
trol group and 43.8% (95% CI 35.5% to 54.7%) for the diet
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group. Incidence of diabetes per 100 person-years was 15.7 (95%
CI 12.7 to 18.7) for the control group and 10.0 (95% CI 7.5 to
12.5) for the diet group which was a significant reduction for the
intervention (P < 0.05).
Time to development or diagnosis of type 2 diabetes mellitus was
not measured in either study.
Glycaemic control measures
Pan (Pan 1997) also reported the incidence of fasting plasma glu-
cose greater than 7.8mmol/L which was 41.4% for the control
group and 16.2% for the dietary intervention group. Incidence of
fasting hyperglycemia per 100 person-years was 9.6 (95% CI 7.2
to 12.0) for the control group, and 3.7 (95% CI 2.1 to 5.3) for
the diet group. Fasting plasma glucose increased by 2.07 ± 0.82
mmol/L in the control group and 1.38 ± 0.81 mmol/L in the diet
group. 2-hour plasma glucose increased by 3.96 ± 0.89 mmol/L
in the control group and 1.48 ± 0.94 mmol/L in the diet arm.
Torjesen (Torjesen 1997) describes only change data for fasting
glucose (mmol/L), which was -0.2 ± 0.1 and 0.0 ± 0.1 and for
post-oral glucose glucose (mmol/L) which was -0.3 ± 0.2 and -0.2
± 0.3 for the diet group and control groups,respectively.
Other outcomes
Pan (Pan 1997) reported no additional or secondary outcomes.
In the Oslo Diet and Exercise Study (Torjesen 1997) weight was
reduced noticably by -6.8 ± 19.5 kg in the diet group compared to
an increase of 1.1 ± 13.8 in the control group. Significant differ-
ences (P < 0.05) were also reported for BMI (kg/m²) -1.3 ± 0.2 for
diet group versus 0.4 ± 0.1 for control group; mean blood pressure
(mBP [mmHg]) -5.2 ± 1.1 for diet versus -1.5 ± 1.5 for control;
fasting triglycerides (mmol/L) -0.3 ± 0.2 for diet versus -0.1 ±
0.3 for control; fasting HDL-cholesterol (mmol/L) 0.06 ±0.04 for
diet versus -0.05 ± 0.03 for control and PAI-1 (U/ml) 0.9 ± 3.8
for diet versus 2.4 ± 3.3 for control group. The aim of the Oslo
Diet and Exercise Study (Torjesen 1997) was to assess the effect of
diet and exercise, either as single interventions, or in combination,
on the development of insulin resistance. The calculated relative
insulin resistance varied widely in participants. However, despite
the large variation, the diet intervention lowered the mean insulin
resistance after 12 months from 4.6 to 4.2. Other significant in-
sulin-related changes (P < 0.05) were fasting insulin (pmol/L) -7
± 4 for diet versus 4 ± 6 for control; fasting C-peptide (pmol/L)
-163 ± 49 for diet versus -92 ± 53 for control; fasting proinsulin
(pmol/L) -2.2 ± 1.1 for diet versus 1.6 ± 1.2 for control and overall
insulin resistance being -0.4 ± 0.2 for dietary intervention and 0.2
± 0.2 for control.
Quality of life, mortality, morbidity, cost of intervention, maximal
exercise capacity and adverse effects were not reported by this
study.
Heterogeneity
Due to the lack of data, tests for heterogeneity could not be per-
formed.
Subgroup analyses
Subgroup analyses were planned, however, due to the lack of data
they could not be carried out. However, Pan (Pan 1997) did re-
port data for lean participants (BMI less than 25kg/m²) and over-
weight participants (BMI greater than 25kg/m²) which would be
interesting analyses to follow up.
Sensitivity analyses
No sensitivity analyses were performed.
Publication and small study bias
Not performed due to small number of studies.
D I S C U S S I O N
Summary
This Cochrane review examined five papers, reporting data from
two large diabetes prevention trials. These were the Da Qing IGT
and Diabetes Study, and the Oslo Diet and Exercise Study, where
dietary advice versus control group data were reviewed for 358
participants. Due to the small amount of data available, no meta-
analyses could be carried out. However, it appears that diet can
have a significant impact on risk factors for the prevention of
diabetes, compared to a control group over a 12 month period.
The Oslo Diet and Exercise Study (Torjesen 1997) found that
many variables changed significantly (P < 0.05) and beneficially
including insulin resistance, fasting insulin (pmol/L), blood glu-
cose and plasma lipoprotein profiles and anthropometric measure-
ments such as weight (kg) and body mass index (kg/ m²).
Over the six year study, Da Qing IGT and Diabetes Study (Pan
1997) found a33%reduction in the incidence of diabetes (P<0.03)
for participants in the diet group, compared to the control group.
The only similar data that were available for the two studies related
to fasting plasma glucose measurements. Fasting plasma glucose
changed by 2.07 ± 0.82 mmol/L in the control group compared
to 1.38 ± 0.81 mmol/L in the diet group after six years in the Da
Qing IGT and Diabetes study (Pan 1997). Fasting plasma glucose
changed by -0.2 ± 0.1 mmol/L in the diet group versus 0.0 ±
0.1 mmol/L in the control group after one year in the Oslo Diet
and Exercise Study (Torjesen 1997). However, due to the varying
time-points at whichmeasurements were taken, more information
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would be required before a comparison of the two different types
of dietary advice can be carried out.
Limitations of the review
The main limitation of this review is the lack of studies and avail-
able related data. Despite the current situation we are facing with
the diabetes epidemic, there are not enough long-term data avail-
able to come to any confident conclusions.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Although only two types of dietary advice were provided in the
trials, common factors were reduction of energy intake and simple
sugars, an increase in fresh fruit and vegetables. Taking this into
account, diets which are similar to those prescribed in the studies,
alongside the frequent contact with dietary advisors, appear to
have a positive effect on minimising the risk factors commonly
associated with the development of diabetes.
Implications for research
Additional research needs to be carried out into the best type of
diet, and the optimal frequency and type of contact with dietary
advisors, to maximise participant compliance to any prescribed
dietary treatments.
Conclusions
Although more evidence is required, the data which are available
do suggest that there are benefits in following an energy-controlled
diet with an increase in consumption of fresh fruit and vegetables,
and a decrease in simple sugars intake. However, another over-
riding factor is the frequency of support and guidance provided by
the dietary advisors, which occurred at least every 3 to 6 months
in both studies, encouraging compliance to the prescribed diets.
More well-designed, long-term studies, providing well-reported,
high-quality data are required before conclusions can bemadewith
confidence into the best dietary advice to give to high-risk patients
for the prevention of diabetes mellitus in adults.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Pan 1997
Methods 110,660 participants from 33 clinics in DaQing, China were screened for IGT and Type 2 diabetes. Using theWHO
criteria, 577 were classified as having IGT and were randomized by clinic to the trial, as a control group or to one of
three intervention groups- diet only, exercise only or diet and exercise. Follow-up evealuations were conducted at 2-
year intervals over a 6-year period to identify individuals who developed NIDDM. In this review, interest is in the
diet only vs control arms of the study
Assessment category: C (two points awarded) - high risk of bias.
Participants 577 participants were randomised by clinic to the groups. Diet only intervention (45% male, 55% female) mean age
44.7 years, and control group (55% male, 45% female), mean age 46.5 years.
Interventions The diet only intervention consisted of dietary advice and prescription of diets. Advice included increasing vegetable
consumption and reducing the intake of alcohol and simple sugars. The diet was to consist of 55% to 65% carbo-
hydrates, 10% to 15% protein and 25% 30% fat. This was provided during group sessions and through individual
counselling.
Outcomes At 2-year intervals, a systematic evaluation of each participant was carried out recording diet and exercise changes
and individual advice on intervention adherence. Height, weight and blood pressure was measured alongside 2-hour
fasting blood glucose. Compared to the control, there was a 33% overall reduction of the incidence of diabetes in
the diet only group (P<0.03
Notes
Torjesen 1997
Methods An unmasked, randomized, 2x2 factorial intervention was carried out with a duration of one year. Patients were
allocated to diet, diet plus exercise, exercise and control groups. For the purpose of this study, focus was on diet only
vs control
Assessment category: C (three points awarded) - high risk of bias.
Participants There were 219 subjects with diastolic blood pressure 86 to 99 mmHg, HDL-cholesterol <1.2 mmol/L, total choles-
terol of 5.20 to 7.74 mmol/L, and BMI >greater than 24 kg/m2. there were 55 participants in the diet group, and
43 in the control group
Interventions The diet included increased intake of fish and reduced total fat intake.
Outcomes After 1 year, the diet intervention significantly reduced BMI by 1.3 kg (P < 0.0001). Mean BMI increased by 0.4
kg/m2 during the intervention period in the control group.
Notes
HbA1c = Glycosylated haemoglobin A1c
BMI = Body mass index
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CG = Control group
IG = Intervention group
NDDG = National Diabetes Data Group
WHO = World Health Organisation
Unless specified, ## ± ## is mean ± SD
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Characteristics of excluded studies [ordered by study ID]
Adam-Perrot 2006 i) not an RCT
Aguillar 1999 i) not an RCT
Angelo 2005 i) not an RCT
Arky 1983 i) not an RCT
Assal 1997 i) not an RCT
Astrup 2001 i) not an RCT
Avenell 2004 i) not an RCT
Barnard 1994 i) not an RCT
Bazzano 2005 i) not an RCT
Bell 2000 i) not an RCT
Bennett 1997 i) not an RCT
Bhoraskar 2005 i) not an RCT
Bloomgarden 1998 i) not an RCT
Bloomgarden 2004 i) not an RCT
Ciliska 1995 i) not an RCT
Clark 1991 i) not an RCT
Connor 2003 i) not an RCT
Costacou 2003 i) not an RCT
Darnton-Hill 2004 i) not an RCT
Davey-Smith 2005 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
de Leiva 1998 i) not an RCT
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(Continued)
Doherty 2006 i) not an RCT
Dyson 1997 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Dyson 2004 i) not an RCT
Enas 2003 i) not an RCT
Entrala-Bueno 2003 i) not an RCT
Eriksson 1991 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Eriksson 1999 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Eschwege 2000 i) not an RCT
Eyre 2004 i) not an RCT
Fernandez-Soto 1990 i) not an RCT
Feskens 1999 i) not an RCT
Florez 1997 i) not an RCT
Franz 2003 i) not an RCT
Fujimoto 2000 i) not an RCT
Gin 2003 i) not an RCT
Goldberg 1998 i) not an RCT
Gruber 2006 i) not an RCT
Haffner 2002 i) not an RCT
Hamdy 2001 i) not an RCT
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(Continued)
Hammam 2006 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Inzucchi 2005 i) not an RCT
Jain 2001 i) not an RCT
Kanaya 2003 i) not an RCT
Klein 2004a i) not an RCT
Klein 2004b i) not an RCT
Knowler 1995 i) not an RCT
Knowler 2002 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Kriska 1994 i) not an RCT
Kriska 2004 i) not an RCT
Laakso 2005 i) not an RCT
Laaksonen 2005 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Lamonte 2005 i) not an RCT
Lean 2003 i) not an RCT
Liao 2002 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Liberopoulos 2006 i) not an RCT
Lindahl 1999 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was intervention
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(Continued)
v) weight loss measured
vi) no measure of diabetic control
Lindstrom 2003 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Lindstrom 2005 i) not an RCT
Maggio 1997 i) not an RCT
Mann 2006a i) not an RCT
Mann 2006b i) not an RCT
Manson 1994 i) not an RCT
McCarty 2000 i) not an RCT
Muller 2004 i) not an RCT
Norris 2005a i) not an RCT
Norris 2005b i) not an RCT
Panzer 2003 i) not an RCT
Pfohl 2001 i) not an RCT
Pittas 2003 i) not an RCT
Pospisilova 2006 i) not an RCT
Quinn 2003 i) not an RCT
Riddle 1997 i) not an RCT
Ruderman 1990 i) not an RCT
Ruhe 2003 i) not an RCT
Ryan 2003 i) not an RCT
Sartorelli 2006 i) not an RCT
Satterfield 2003 i) not an RCT
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(Continued)
Schernthaner 2003 i) not an RCT
Schonthal 1999 i) not an RCT
Schulze 2005 i) not an RCT
Schwarz 2006 i) not an RCT
Simpson 2003 i) not an RCT
Steyn 2004 i) not an RCT
Thompson 2001 i) not an RCT
Toeller 2005 i) not an RCT
Tuomilehto 1992 i) not an RCT
Tuomilehto 2001 i) is an RCT
ii) follow up >12 months
iii) participants >18 years old
iv) dietary advice was not the intervention
Uusitupa 2005 i) not an RCT
Uutela 2004 i) not an RCT
Venkat Narayan 2003 i) not an RCT
Vidal 2005 i) not an RCT
Vijgen 2006 i) not an RCT
Warnken 2005 i) not an RCT
Weickert 2005 i) not an RCT
Williamson 2004 i) not an RCT
Wylie-Rosett 2006 i) not an RCT
Yamaoka 2005 i) not an RCT
Zeman 2005 i) not an RCT
NB1. Any “no” disqualifies study from inclusion.
NB2. If excluded because they are “treatment studies”, these have been included in a previously published treatment review.
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D A T A A N D A N A L Y S E S
Comparison 1. Dietary Advice vs Control




participants Statistical method Effect size
1 Fasting blood glucose (mmol/l)
at 1 year
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Insulin resistance at 1 year 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 % B-cell function at 1 year 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Development of diabetes 0 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 % developing diabetes
(defined by WHO criteria
[2-hour plasma glucose
>11.1mmol/l]) at 6 years
0 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.2 Incidence of diabetes
(defined using WHO criteria)
per 100 person years at 6 years
0 Mean Difference (IV, Fixed, 95% CI) Not estimable
5 Fasting C-peptide (pmol/l) at 1
year
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6 Fasting blood glucose (mmol/l)
at 6 years
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7 Fasting hyperglycemia 0 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 defined using fasting
glucose >140mg/dl [7.8mmol]
per 100 person years at 6 years
0 Mean Difference (IV, Fixed, 95% CI) Not estimable
7.2 % incidence of fasting
glucose >140mg/dl [7.8mmol/
l]
0 Mean Difference (IV, Fixed, 95% CI) Not estimable
8 Fasting proinsulin (pmol/l) at 1
year
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9 Post-oral glucose glucose (mmol/
l) at 1 year
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10 Fasting triglycerides (mmol/l)
at 1 year
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11 Fasting HDL-cholesterol
(mmol/l)
1 95 Mean Difference (IV, Fixed, 95% CI) 0.11 [0.10, 0.12]
12 PAI-1 (U/ml) at 1 year 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
13 2-hour blood glucose (mmol/l)
at 6 years
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
14 mBP (mmHg) at 1 year 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
15 BMI (kg/m2) at 1 year 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
16 Weight (kg) at 1 year 0 Mean Difference (IV, Fixed, 95% CI) Totals not selected
17 Fasting insulin (pmol/l) at 1
year
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Analysis 1.1. Comparison 1 Dietary Advice vs Control, Outcome 1 Fasting blood glucose (mmol/l) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 1 Fasting blood glucose (mmol/l) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -0.2 (0.1) 43 0 (0.1) -0.20 [ -0.24, -0.16 ]
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.2. Comparison 1 Dietary Advice vs Control, Outcome 2 Insulin resistance at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 2 Insulin resistance at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -0.4 (0.2) 43 0.2 (0.2) -0.60 [ -0.68, -0.52 ]
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.3. Comparison 1 Dietary Advice vs Control, Outcome 3 % B-cell function at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 3 % B-cell function at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 6.8 (6.8) 43 3.5 (10.9) 3.30 [ -0.45, 7.05 ]
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.5. Comparison 1 Dietary Advice vs Control, Outcome 5 Fasting C-peptide (pmol/l) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 5 Fasting C-peptide (pmol/l) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -163 (49) 43 -92 (53) -71.00 [ -91.70, -50.30 ]
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.6. Comparison 1 Dietary Advice vs Control, Outcome 6 Fasting blood glucose (mmol/l) at 6
years.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 6 Fasting blood glucose (mmol/l) at 6 years
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pan 1997 130 1.38 (0.81) 133 2.07 (0.82) -0.69 [ -0.89, -0.49 ]
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.8. Comparison 1 Dietary Advice vs Control, Outcome 8 Fasting proinsulin (pmol/l) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 8 Fasting proinsulin (pmol/l) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -2.2 (1.1) 43 1.6 (1.2) -3.80 [ -4.27, -3.33 ]
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.9. Comparison 1 Dietary Advice vs Control, Outcome 9 Post-oral glucose glucose (mmol/l) at 1
year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 9 Post-oral glucose glucose (mmol/l) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -0.3 (0.2) 43 -0.2 (0.3) -0.10 [ -0.20, 0.00 ]
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.10. Comparison 1 Dietary Advice vs Control, Outcome 10 Fasting triglycerides (mmol/l) at 1
year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 10 Fasting triglycerides (mmol/l) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -0.3 (0.2) 43 -0.1 (0.3) -0.20 [ -0.30, -0.10 ]
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.11. Comparison 1 Dietary Advice vs Control, Outcome 11 Fasting HDL-cholesterol (mmol/l).
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 11 Fasting HDL-cholesterol (mmol/l)
Study or subgroup Treatment Control Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 0.06 (0.04) 43 -0.05 (0.03) 100.0 % 0.11 [ 0.10, 0.12 ]
Total (95% CI) 52 43 100.0 % 0.11 [ 0.10, 0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 15.30 (P < 0.00001)
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.12. Comparison 1 Dietary Advice vs Control, Outcome 12 PAI-1 (U/ml) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 12 PAI-1 (U/ml) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 0.9 (3.8) 43 2.4 (3.3) -1.50 [ -2.93, -0.07 ]
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.13. Comparison 1 Dietary Advice vs Control, Outcome 13 2-hour blood glucose (mmol/l) at 6
years.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 13 2-hour blood glucose (mmol/l) at 6 years
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pan 1997 130 1.48 (0.94) 133 3.96 (0.89) -2.48 [ -2.70, -2.26 ]
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.14. Comparison 1 Dietary Advice vs Control, Outcome 14 mBP (mmHg) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 14 mBP (mmHg) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -5.2 (1.1) 43 -1.5 (1.5) -3.70 [ -4.24, -3.16 ]
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.15. Comparison 1 Dietary Advice vs Control, Outcome 15 BMI (kg/m2) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 15 BMI (kg/m2) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -1.3 (0.2) 43 0.4 (0.1) -1.70 [ -1.76, -1.64 ]
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.17. Comparison 1 Dietary Advice vs Control, Outcome 17 Fasting insulin (pmol/l) at 1 year.
Review: Dietary advice for the prevention of type 2 diabetes mellitus in adults
Comparison: 1 Dietary Advice vs Control
Outcome: 17 Fasting insulin (pmol/l) at 1 year
Study or subgroup Treatment Control Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Torjesen 1997 52 -7 (4) 43 4 (6) -11.00 [ -13.10, -8.90 ]
-10 -5 0 5 10
Favours treatment Favours control
A P P E N D I C E S
Appendix 1. Search strategy
Search terms
NOTE: Unless otherwise stated, search terms are free text terms; MeSH: Medical subject heading (MEDLINE medical index
term); a dollar sign stands for ’any character(s)’ and a question mark stands for an ’optional character’. This search was created
for use with the OVID gateway.
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(Continued)
Adj: The adjacency operator (adjn) retrieves two or more query terms within n words of each other, (any order). The number n
may be any number from 1 through 99, and immediately follows adj without a space, as in adj7, adj3 etc.
Explode: In order to search for all the terms that are more specific than the original term, as well as the original term, you
’explode’ that term. For example, if you explode the term ’Wounds and Injuries’, your search will include all the specific types of
wounds such as burns, contusions, and fractures.
TYPE 2 DIABETES MELLITUS
1. exp diabetes mellitus, Type II/
2. exp insulin resistance/
3. impaired glucose toleranc$.tw.
4. glucose intoleranc$.tw.
5. insulin$ resistanc$.tw.
6. exp obesity in diabetes/
7. (obes$ adj diabet$).tw.
8. (MODY or NIDDM).tw.
9. (non insulin$ depend$ or noninsulin$ depend$ or noninsulin?depend$ or non insulin?depend$).tw.
10. ((typ$ 2 or typ$ II) adj diabet$).tw.
11. ((keto?resist$ or non?keto$) adj diabet$).tw.
12. ((adult$ or matur$ or late or slow or stabl$) adj diabet$).tw
13. (insulin$ defic$ adj relativ$).tw.
14. pluri?metabolic$ syndrom$.tw.
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14
16. exp diabetes insipidus/
17. diabet$ insipidus.tw.
18. 16 or 17
19. 15 not 18
DIET INTERVENTIONS
20. explode Diet Therapy/ [MeSH, all subheadings]
21. Explode Diet/ [MeSH, all subheadings]
22. Nutrition/[MeSH, all subheadings]
23. (diet$ adj5 diabet$).ab,ti.
24. (diet$ adj5 carbohydrat$).ab,ti.
25. (diet$ adj5 fat$).ab,ti.
26. (diet$ adj5 weigh$).ab,ti.
27. (diet$ adj5 sugar$).ab,ti.
28. (diet$ adj5 glyc?em$).ab,ti.
29. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
SYSTEMATIC REVIEWS/META-ANALYSIS
30. exp meta-analysis/
31. exp Review Literature/
32. meta-analysis.pt.
33. review.pt.
34. 30 or 31 or 32 or 33
35. letter.pt.
36. comment.pt.
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39. 35 or 36 or 37 or 38
40. 34 not 39
41. ((systematic$ or quantitativ$ or methodologic$)adj (review$ or overview$)).tw.
42. meta?anal$.tw.
43. (integrativ$ research review$ or research integration$).tw.
44. quantitativ$ synthes$.tw.
45. (pooling$ or pooled analys$ or mantel$ haenszel$).tw.
46. (peto$ or der?simonian$ or fixed effect$ or random effect$).tw.
47. 41 or 42 or 43 or 44 or 45 or 46
48. 40 or 47
49. limit 48 to human
RANDOMISED CONTROLLED TRIALS
50. randomized controlled trial.pt.
51. randomized controlled trials/[MeSH, all subheadings]
52. controlled clinical trial.pt.
53. random allocation/[MeSH, all subheadings]
54. double blind method/[MeSH, all subheadings]
55. single-blind method/[MeSH, all subheadings]
56. 50 or 51 or 52 or 53 or 54 or 55
57. clinical trial.pt.
58. explode clinical trials/[MeSH, all subheadings]
59. (clin$ adj5 trial$).tw.
60. ((singl$ or doubl$ or trebl$ or tripl$) adj5 (blind$ or mask$)).tw.
61. placebos/[MeSH, all subheadings]
62. placebo$.tw.
63. random$.tw.
64. research design/[MeSH, all subheadings]
65. 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64
66. comparative study/[MeSH, all subheadings]
67. explode evaluation studies/[MeSH, all subheadings]
68. follow up studies/[MeSH, all subheadings]
69. prospective studies/[MeSH, all subheadings]
70. (control$ or prospectiv$ or volunteer$).tw.
71. 66 or 67 or 68 or 69 or 70
72. animal/ not (human/ and animal/)
73. 56 or 65 or 71
74. 73 not 72
TYPE 2 DIABETES AND DIETARY INTERVENTIONS
75. 19 and 29
TYPE 2 DIABETES AND DIETARY INTERVENTIONS AND RANDOMISED CONTROLLED TRIALS
76. 75 and 74
TYPE 2 DIABETES AND DIETARY INTERVENTIONS AND SYSTEMATIC REVIEW/META-ANALYSES
53. 75 and 49
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(Continued)
The MEDLINE search will be run as above, with the randomised controlled trials and systematic reviews searches added on
separately.
The CINAHL search will be run as above, with randomised controlled trials search added on separately.
The AMED search will be run as above, with randomised controlled trials search added on separately.
The EMBASE search will be adapted from the original search above.
Appendix 2. Study quality
Characteristic Pan 1997 Torjesen 1997






Randomised controlled clinical trial (RCT) Y Y
Non-inferiority / equivalence trial ? ?
Controlled clinical trial Y Y
Design: parallel, crossover, factorial RCT ? Y
Design: crossover study ? Y
Design: factorial study ? Y
Crossover study: wash-out phase ? ?
Crossover study: carryover effect tested ? ?
Crossover study: period effect tested ? ?
Method of randomisation (specify) By Clinic Stratified by gender
Unit of randomisation (individuals, cluster
- specify)
Cluster Individuals
Randomisation stratified for centres Y N
Randomisation ratio ? ?
Concealment of allocation (specify) N N
37Dietary advice for the prevention of type 2 diabetes mellitus in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Stated blinding (open; single, double, triple
blind)
? ?
Actual blinding: participant N N
Actual blinding: caregiver / treatment ad-
ministrator
? ?
Actual blinding: outcome assessor ? Y
Actual blinding: others ? ?
Blinding checked: participant ? ?
Blinding checked: caregiver / treatment ad-
ministrator
? ?
Primary endpoint defined N N
[n] of primary endpoint(s) 2 12
[n] of secondary endpoints 3 ?
Total [n] of endpoints 5 12
Prior publication of study design Y Y
Outcomes of prior and current publication
identical
Y Y
Power calculation ? ?
[n] participants per group calculated ? ?
Non-inferiority trial: interval for equiva-
lence specified
? ?
Intention-to-treat analysis (ITT) ? ?
Per-protocol-analysis Y Y




Missing data: other methods ? ?
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(Continued)
LOCF defined ? ?
[n] of screened participants (I1/ I2 / C1 /
total)
110,660 26,000
[n] of randomised participants (for primary
endpoint)
Total: 1207 (in all 4 groups) Total: 209 (in all 4 groups)
98 (in the 2 groups studied)
[n] of participants finishing the study 577 (total of 4 groups)
169 (in the 2 groups studied)
Total: 209 (in all 4 groups)
98 (in the 2 groups studied)
[n] of patients analysed (for primary end-
point)
530 (total of 4 groups)
163 (in the 2 groups studied)
Total: 209 (in all 4 groups)
98 (in the 2 groups studied)
Description of discontinuing participants Seven people refused follow-up, 29 left Da
Qing in 1988 and eleven died from non-
diabetic related illnesses. In the control
group, there was one from pneumonia and
two from cirrhosis, and three in the diet
group (two from cancer, and one from sep-
ticaemia).
Drop-outs (reasons explained) 7 refused follow-up
Withdrawals (reasons explained) 29 left Da Qing in 1988
Losses-to-follow-up (reasons explained) 11 died (in total of 4 groups)
6 died (in 2 groups studied)
[n] of participants who discontinued 47
[%] discontinuation rate 8%
Discontinuation rate similar between
groups
Y
[%] crossover between groups ?
Differences [n] calculated to analysed pa-
tients
? ?
Adjustment for multiple outcomes / re-
peated measurements
? ?
Baseline characteristics: clinically relevant
differences
? ?
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(Continued)
Treatment identical (apart from interven-
tion)
Y ?
Compliance measured ? Y
Other important covariates measured
(specify)
? ?
Co-morbidities measured ? ?
Co-medications measured ? ?
Specific doubts about study quality
Funding: commercial ? ?
Funding: non-commercial ? ?
Publication status: peer review journal Y Y
Publication status: journal supplement N N
Publication status: abstract N N
Publication status: other N N
Notes
Symbols & abbreviations: Y = yes; N = no;
? = unclear I = intervention; C = control
Appendix 3. Baseline characteristics
Characteristic Torjesen (1997) Pan (1997)
Dietary Intervention 1 / control 1 (C1) I1: increase of fish and reduced total fat
intake
C1: no prescribed dietary advice
I1: A diet was prescribed containing 25-
30 kcal/kg body weight, 55-65% carbohy-
drate, 10-15% protein, and 25-30% fat.
Encouraged to eat more vegetables, control
alcohol and reduce intake of simple sugars
C1: General information and brochures re-
garding general instruction for diet and in-
creasing physical activity.
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(Continued)















Ethnic groups [%] not stated not stated
Insulin Resistance I1: 4.60 (2.10)
C1: 4.89 (4.64)
Weight [kg] mean (SD) I1: 92.73 (19.48)
C1: 89.33 (13.77)




B-cell function [%] mean (SD) I1: 179 (71)
C1: 207 (107)
Fasting Insulin [pmol/l] mean (SD) I1: 130 (52)
C1: 142 (108)
Fasting C-Peptide [pmol/l] mean (SD) I1: 1073 (473)
C1: 1111 (686)
Fasting proinsulin [pmol/l] mean (SD) I1: 14 (11)
C1: 15 (22)
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2 hour glucose [mmol/l] mean (SD) I1: 9.03 (0.94)
C1: 9.03 (0.89)
mBP [mmHg] mean (SD) I1: 100 (10)
C1: 98 (8)
Fasting Triglycerides [mmol/l] mean (SD) I1: 2.39 (1.35)
C1: 2.29 (0.84)




PAI-1 [U/ml] mean (SD) I1: 22 (17)
C1: 18 (14)
Notes
Symbols & abbreviations: Y = yes; N = no;
? = unclear
I = intervention; C = control
Appendix 4. Adverse events
Characteristic Pan 1997 Torjesen 1997






[n] of participants who died 11 ?
[n] adverse events (I1/ I2 / C1 / total) I1: 3
C: 3
?
[%] adverse events 8% ?
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[n] serious adverse events ? ?
[%] serious adverse events ? ?





[%] drop-outs due to adverse events ? ?
[n] hospitalisation ? ?
[%] hospitalisation ? ?
[n] out-patient treatment ? ?
[%] out-patient treatment ? ?
[n] hypoglycaemic episodes ? ?
[%] hypoglycaemic episodes ? ?
[n] severe hypoglycaemic episodes ? ?
[%] severe hypoglycaemic episodes ? ?
[n] nocturnal hypoglycaemic episodes ? ?
[%] nocturnal hypoglycaemic episodes ? ?
[n] with symptoms ? ?
[%] with symptoms ? ?
Symbols & abbreviations: Y = yes; N = no;
? = unclear I = intervention; C = control
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Appendix 5. Primary outcome data









Symbols & abbreviations: ? =
unclear;
I = intervention; C = control
Appendix 6. Secondary outcome data














Symbols & abbreviations: ? = unclear;
I = intervention; C = control
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WH A T ’ S N E W
Last assessed as up-to-date: 31 October 2007.
5 May 2008 Amended Converted to new review format.
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Review first published: Issue 3, 2008
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inclusion criteria, appraising quality of papers, abstracting data from papers,data management for the review.
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N O T E S
Currencies converted on 21st September 2004
Exchange rate: 1 US dollar = 0.821558EUR ( $1 = EURO0.821558)
www.x-rates.com was used to convert
I N D E X T E R M S
Medical Subject Headings (MeSH)
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MeSH check words
Adult; Humans
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